Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Walford

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Newsweek|January 25, 2007
Is male menopause real?Daniel D Federman, Geoffrey A Walford
Plos One|February 22, 2020
Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention ProgramDeepak K Gupta, Geoffrey A Walford, Yong Ma, et al.
The Journal of Biological Chemistry|November 5, 2003
Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathwaysGeoffrey A Walford, Rose-Laure Moussignac, Anne W Scribner, et al.
Journal of Diabetes Science and Technology|September 5, 2017
Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for TherapyAmit R Majithia, Alexander B Wiltschko, Hui Zheng, et al.
Clinical and Translational Science|January 24, 2024
Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studiesKelly E Duncan, Runcheng Li, Lata Maganti, et al.
Diabetes, Obesity & Metabolism|July 13, 2019
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetesYuan-Di C Halvorsen, Geoffrey A Walford, Joseph Massaro, et al.
Food & Nutrition Research|January 20, 2016
A pilot, short-term dietary manipulation of branched chain amino acids has modest influence on fasting levels of branched chain amino acidsNicole Landa Cavallaro, Jamie Garry, Xu Shi, et al.
Diabetes|February 11, 2016
Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention ProgramGeoffrey A Walford, Yong Ma, Clary Clish, et al.
Clinical Pharmacology and Therapeutics|April 7, 2022
A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin DimerGeoffrey A Walford, Kelly E Duncan, Moises Hernandez, et al.
Clinical Pharmacology and Therapeutics|June 13, 2023
Considerations for Cell and Gene Therapy Programs Entering the Clinical SpaceGeoffrey A Walford, An Bautmans, Carol Cannon, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Newsweek|January 25, 2007
Is male menopause real?Daniel D Federman, Geoffrey A Walford
Plos One|February 22, 2020
Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention ProgramDeepak K Gupta, Geoffrey A Walford, Yong Ma, et al.
The Journal of Biological Chemistry|November 5, 2003
Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathwaysGeoffrey A Walford, Rose-Laure Moussignac, Anne W Scribner, et al.
Journal of Diabetes Science and Technology|September 5, 2017
Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for TherapyAmit R Majithia, Alexander B Wiltschko, Hui Zheng, et al.
Clinical and Translational Science|January 24, 2024
Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studiesKelly E Duncan, Runcheng Li, Lata Maganti, et al.
Diabetes, Obesity & Metabolism|July 13, 2019
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetesYuan-Di C Halvorsen, Geoffrey A Walford, Joseph Massaro, et al.
Food & Nutrition Research|January 20, 2016
A pilot, short-term dietary manipulation of branched chain amino acids has modest influence on fasting levels of branched chain amino acidsNicole Landa Cavallaro, Jamie Garry, Xu Shi, et al.
Diabetes|February 11, 2016
Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention ProgramGeoffrey A Walford, Yong Ma, Clary Clish, et al.
Clinical Pharmacology and Therapeutics|April 7, 2022
A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin DimerGeoffrey A Walford, Kelly E Duncan, Moises Hernandez, et al.
Clinical Pharmacology and Therapeutics|June 13, 2023
Considerations for Cell and Gene Therapy Programs Entering the Clinical SpaceGeoffrey A Walford, An Bautmans, Carol Cannon, et al.
Pageof 3